Traditional pharmacological treatments for spasticity part I: Local treatments

Muscle and Nerve

Volumn 20, Issue SUPPL. 6, 1997, Pages

  Gracies, Jean Michel ^a   Elovic, Elie ^b   McGuire, John ^c   Simpson, David ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JFK JOHNSON REHABILITATION INSTITUTE   (United States)

^c REHABILITATION INSTITUTE OF CHICAGO   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Bipuvicaine; Botulinum toxin; Ethyl alcohol; Etidocaine; Lidocaine; Local anesthetic; Muscle overactivity; Neurolysis; Phenol; Spasticity

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; LOCAL ANESTHETIC AGENT;

ADULT; HUMAN; NEUROMUSCULAR DISEASE; REVIEW; SPASTICITY;

ADULT; ANESTHETICS, LOCAL; HUMANS; MUSCLE SPASTICITY; NEUROMUSCULAR DISEASES; PARASYMPATHOLYTICS;

EID: 0002738202     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (150)

1. Denny-Brown D: The Cerebral Control of Movement. Liverpool University Press, Liverpool, 1966.
2. Tardieu C, Tardieu G, Colbeau-Justin P, Huet de la Tour E, Lespargot A: Trophic muscle regulation in children with congenital cerebral lesions. J Neurol Sci 1979; 42:357-364.
3. Lance JW: Symposium synopsis, in Feldman RG, Young RR, Koella WP (eds): Spasticity: Disordered Motor Contro. Chicago, Yearbook Medical, 1980, pp 485-494.
4. Tardieu G, Shentoub S, Delarue R: À la récherche d'une technique de mesure de la spasticité. Revue Neurol 1954; 91(2):143-144.
5. Ashworth B: Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964; 192:540-542.
6. Landau WM: Spasticity: the fable of a neurological demon and the emperors new therapy. Arch Neurol 1974; 31:217-219.
7. Sahrmann SA, Norton BJ: The relationship of voluntary movement to spasticity in the upper motor neuron syndrome. Ann Neurol 1977; 2:460-465.
8. Eken T, Hultborn H, Kiehn O: Possible functions of transmitter-controlled potentials in α-motoneurons. Prog Brain Res 1989; 80:257-267.
9. Gracies J-M, Wilson L, Grandevia SC, Burke D: Stretched position of spastic muscles aggravates their co-contraction in hemiplegic patients. 122nd annual meeting of the American Neurological Association, San Diego, Sept 1997, abstract #183.
10. Pollock LJ, Davis L: Studies in decerebration. VI. The effects of deafferentation upon decerebrate rigidity. Am J Physiol 1930; 98:47-49.
11. Huet de la Tour E, Tardieu C, Tabary JC, Tabary C: Decrease of muscle extensibility and reduction of sarcomere number in soleus muscle following local injection of tetanus toxin. J Neurol Sci 1979; 40:123-131.
12. Tabary JC, Tabary C, Tardieu C, Tardieu G, Goldspink G: Physiological and structural changes in cat's soleus muscle due to immobilization at different lengths by plaster casts. J Physiol (Lond) 1972; 224:231-244
13. Ada L, Canning C: Anticipating and avoiding muscle shortening, in Ada L, Canning C (eds): Keys Issues in Neurological Physiotherapy. Carr JH, Shepherd RB (eds): Physiotherapy: Foundations for Practice. Oxford, Butterworth-Heinemann Ltd, 1990.
14. Held JP, Pierrot-Deseilligny E: Rééducation Motrice des Affections Neurologiques. Paris, JB Baillére, 1969; pp 31-42.
15. Gioux M, Petit J: Effects of immobilising the cat peroneus longus muscle on the activity of its own spindles. J Appl Physiol 1993; 75(6):2629-2635.
16. Maier A, Eldred E, Edgerton VR: The effects on spindles of muscle atrophy and hypertrophy. Exp Neurol 1972; 37:100-123.
17. Williams RG: Sensitivity changes shown by spindle receptors in chronically immobilized skeletal muscle. J Physiol (Lond) 1980; 306:26P-27P.
18. Gracies J-M, Marosszeky JE, Renton R, Sandanam J, Ballantyne J, Gandevia SC, Burke D: Immediate effects of dynamic lycra splints on upper limb in hemiplegic patients. Ann Neurol 1997; 78:1066-1071.
19. O'Dwyer NJ, Ada L, Neilson PD: Spasticity and muscle contracture following stroke. Brain 1996; 119:1737-1749.
20. Lund S, Lundberg A, Vyklicky L: Inhibitory action from the flexor reflex afferents on transmission to Ia afferents. Acta Physiol Scand 1965; 64:345-355.
21. Emre M: New developments in the medical treatment of spasticity, in Thilman, Burke, Rymer (eds): Spasticity: Mechanisms and Management. Berlin-Heidelberg, Springer-Verlag, 1993.
22. Tardieu C, Lespargot A, Tabary C, Bret MD: For how long must the soleus muscle be stretched each day to prevent contracture? Dev Med Child Neurol 1988; 30:3-10.
23. Feldman PA: Upper Extremity Casting and Splinting, in Glenn, Whyte (eds): The Practical Management of Spasticity in Children and Adults. Lea & Febiger, Philadelphia, 1990.
24. Gracies JM, Fitzpatrick R, Wilson L, Burke D, Gandevia SC: Lycra garments designed for patients with upper limb spasticity: mechanical effects in normal subjects. Arch Phys Med Rehabil 1997; (In press).
25. Liljestrand G, Magnus R: Über die Wirkung des Novocaine auf den normalen und den tetanusstarren Skelettmuskel und Über die Entstehung der Muskelstaue beim Wundstarrkampf. Pflügers Arch Ces Physiol 1919; 176:168-208.
26. Liddell EGT, Sherrington CS: Reflexes in response to stretch (myotatic reflexes). Proc Royal Soc Lond 1924 series B, 96:212-242.
27. Kuffler SW, Hunt CC, Quilliam JP: Function of medullated small-nerve fibers in mammalian ventral roots: efferent muscle spindle innervation. J Neurophysiol 1951; 14:29-54.
28. Ritchie JM, Greene NM: Local anesthetics, in Goodman LS, Gilman A (ed): The Pharmacological Basis of Therapeutics, 6th edition. New York, Macmillan, 1980, pp 300-320.
29. Bohbot V Otahal P, Liu Z, Nadel L, Bures J: Electroconvulsive shock and lidocaine reveal rapid consolidation of spatial working memory in the water maze. Proc Natl Acad Sci USA. 1996; 93(9):4016-4019.
30. Gasser HS, Erlanger J: The role of fiber size in the establishment of a nerve block by pressure or cocaine. Am J Physiol 1929; 88:581-591.
31. Matthews PBC, Rushworth G: The relative sensitivity of muscle nerve fibers to procaine. J Physiol (Lond) 1957; 135:263-269.
32. Franz DN, Perry RS: Mechanisms for differential blocks among single myelinated and non-myelinated axons by procaine. J Physiol (Lond) 1974; 236:193-210.
33. Hariga J: Influences sur la motricité de la suppression des effecteurs gamma par alcoolisation des nerfs périphériques. Acta Neurol Belg 1966; 66: 607-611.
34. Khalili AA, Benton JG: A physiological approach to the evaluation and the management of spasticity with procaine and phenol nerve block. Clin Orthop 1966; 47:97-104.
35. Kjellberg RN, et al.: Gait improvement in parkinsonian patients by gamma motor neuron suppression. Trans Am Neurol Assoc 1961; 86: 126-130.
36. Burke D, Lance JW: Pathophysiology of spasticity. Studies of the reflex effects of primary and secondary spindle endings in spasticity, in Desmedt JE (ed): New Developments in Electromyography and Clinical Neurophysiology, Volume 3. Karger, Basel, 1973,pp 475-495.
37. Bromage PR, Datta S, Dunford LA: An evaluation of etidocaine in epidural analgesia for obstetrics. Can Anaesth Soc J 1974; 21:535-545.
38. Vallbo AB: Afferent discharge from human muscle spindles in non-contracting muscles. Steady state impulse frequency as a function of joint angle. Acta Physiol Scand 1974; 90:303-318.
39. Wilson LR, Gandevia SC, Inglis JT, Gracies JM, Burke D: Muscle spindle afferent activity in the affected upper limb following stroke. XXXIII International Congress of Physiological Sciences IUPS, St Petersburg, 1997.
40. Harvey AM: The actions of procaine on neuromuscular transmission. Bull Johns Hopkins Hosp 1939; 65:223-238.
41. de Jong RH: Local Anesthetics. Springfield, Charles C. Thomas, 1977.
42. Ruff RL: A quantitative analysis of local anaesthetic alteration of miniature end-plate currents and end-plate current fluctuations. J Physiol (Lond) 1977; 264:89-124.
43. Sotgiu ML, Lacerenza M, Marchettini P: Effect of systemic lidocaine on dorsal horn neuron hyperactivity following chronic peripheral nerve injury in rats. Somatosens Mot Res 1992; 9(3):227-233.
44. Hesse S, Jahnke MT, Luecke D, Mauritz KH: Short-term electrical stimulation enhances the effectiveness of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 1995; 201:37-40.
45. Karatassas A, Morris RG, Slavotinek AH: The relationship between regional blood flow and absorption of lignocaine. Aust N Z J Surg 1993; 63(10): 766-771.
46. Hogan QH, Stadnicka A, Stekiel TA, Bosnjak ZJ, Kampine JP: Effects of epidural and systemic lidocaine on sympathetic activity and mesenteric circulation in rabbits. Anesthesiology 1993; 79(6): 1250-1260.
47. Berntsen RF, Rasmussen K: Lidocaine to prevent ventricular fibrillation in the prehospital phase of suspected acute myocardial infarction: the North-Norwegian Lidocaine Intervention Trial. Am Heart J 1992; 124(6):1478-1483.
48. Kalichmann MW, Moorhouse DF, Powell HC, Myers RR: Relative neural toxicity of local anesthetics. J Neuropathol Exp Neurol 1993; 52(3): 234-240.
49. Kaji R, Rothwell JC, Katayama M, Ikeda T, Kubori T, Kohara N, Mazaki T, Shibasaki H, Kimura J: Tonic vibration reflex and muscle afferent block in writer's cramp. Ann Neurol 1995; 38:155-162.
50. Kiernan MC, Hales JP, Gracies JM, Mogyoros I, Burke D: Paraesthesiae induced by prolonged high frequency stimulation of human cutaneous afferents. J Physiol (Lond) 1997; (In press).
51. Kalichman MW, Calcutt NA: Local anesthetic-induced conduction block and nerve fiber injury in streptozotocin-diabetic rats. Anesthesiology 1992; 77(5):941-947.
52. Koman LA, Mooney JF, Patersen Smith B: Neuromuscular blockade in the management of cerebral palsy. J Child Neurol 1996; 11(Suppl 1): S23-S28.
53. Glenn MB: Nerve Blocks, in Glenn, Whyte (eds): The Practical Management of Spasticity in Children and Adults. Philadelphia, Lea & Febiger, 1990, pp 227-258.
54. Carpenter EB: Role of nerve blocks in the foot and ankle in cerebral palsy: therapeutic and diagnostic. Foot Ankle 1983; 4:164-166.
55. Gracies JM, Wilson L, Gandevia SC, Burke D: Quantitative assessment of spasticity, proprioception, passive and active range of motion, and dynamometric isometric strength after injections of botulinum toxin type A into the forearm flexors of hemiplegic patients. (Unpublished).
56. Schichor A, Bernstein B, Weinermann H, Fitzgerald J, Yordan E, Schechter N: Lidocaine as a diluent for ceftriaxone in the treatment of gonorrhea. Does it reduce the pain of injection? Arch Pediatr Adolesc Med 1994; 148(1):72-75.
57. Eriksson M: Prilocaine reduces injection pain caused by Propofol. Acta Anaesthesiol Scand 1995; 39(2):210-213.
58. Tardieu G, Hariga J, Tardieu C, Gagnard L, Vélin J: Traitement de la spasticité par infiltration d'alcool dilué aux points moteurs, ou par injectioné épidurale. Rev Neurol 1964; 110(6):563-566.
59. Hasegawa O, Nagatomo H, Suzuki Y: Local alcoholisation treatment of spasmodic torticollis. Rinsho Shinkeigaku 1990; 30(7):718-722.
60. Stav A, Ovadia L, Sternberg A, Kaadan M, Weksler N: Cervical epidural steroid injection for cervico-brachialgia. Acta Anaesthesiol Scand 1993; 37(6): 562-566.
61. Hong CZ, Long HA, Kanakamedala RV, Chang YM, Yates L: Splinting and local steroid injection for the treatment of ulnar neuropathy at the elbow: clinical and electrophysiological evaluation. Arch Phys Med Rehabil 1996; 77(6):573-577.
62. Martin C, Thomachot L, Albanese J: Clinical pharmacokinetics of cefotetan. Clin Pharmacokinet 1994; 26(4):248-258.
63. Nathan PW: Intrathecal phenol to relieve spasticity in paraplegia. Lancet 1959; ii:1099-1102.
64. Kelly RE, Gauthier-Smith PC: Intrathecal phenol in the treatment of reflex spasms and spasticity. Lancet 1959; ii:1102-1105.
65. Khalili AA, Harmel MH, Forster S, Benton JG: Management of spasticity by selective peripheral nerve block with dilute phenol solutions in clinical rehabilitation. Arch Phys Med Rehab 1964; 45: 513-519.
66. Halpern D, Meelhuysen FE: Phenol motor point block in the management of muscular hypertonia. Arch Phys Med Rehab 1966; 47:659-664.
67. Tardieu G, Tardieu C, Hariga J, Gagnard L, Joly C: Action des infiltrations d'alcool dilué sur diverses raideurs liés aux lésions cérébrales. Bull Mem Soc Méd Hop Paris 1962, 113(1):7-12.
68. Hariga J, Tardieu G, Tardieu C, Gagnard L: Effets de l'application de l'alcool dilué sur le nerf. Confrontation de l'étude dynamographique et de l'étude histologique chez le chat décérébré. Revue Neurol (Paris) 1964; 111:472-474.
69. Nathan PW, Sears TA, Smith MC. Effects of phenol solutions on the nerve roots of the cat: an electrophysiological and histological study. J Neurol Sci 1965; 2:7-29.
70. Tardieu C, Tardieu G, Hariga J, Gagnard L, Vélin J. Fondement expérimental d'une thérapeutique des raideurs d'origine cérébrale (effets de l'alcoolisation ménagée nerf moteur sur le réflexe d1 étirement de l'animal décérébré). Arch Fr Pédiatr 1964; 21:5-23.
71. Tardieu G, Tardieu C, Hariga J, Gagnard L: Treatment of spasticity by injection of dilute alcohol at the motor point or by epidural route. Clinical extension of an experiment on the decerebrate cat. Dev Med Child Neurol 1968; 10:555-568.
72. Yadav SL, Singh U, Dureja GP, et al.: Phenol block in the management of spastic cerebral palsy. Indian J Pediatr 1994; 61:249-255.
73. May O: The functional and histological effects of intraneural and intraganglionic injections of alcohol. Br Med J. 1912; Aug 31:465-470 .
74. Gordon A: Experimental study of intraneural injections of alcohol. J Nerv Ment Dis 1914; 41: 81-95.
75. Ritchie JM: The Aliphatic Alcohols, in Goodman LS, Gilman A (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, 6th edition. New York, Macmillan, 1980, pp 376-390.
76. Labat G: The action of alcohol on the living nerve: experimental and clinical considerations. Anesth Analg (Current Researches) 1933, 12:190-196.
77. Fisher E, et al.: Evoked nerve conduction after nerve block by chemical means. Am J Phys Med 1970; 49:333-347.
78. Brazeau GA, Fung HL: Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems. Pharm Res 1989; 6(9):766-771.
79. Carpenter EB, Seitz DG: Intramuscular alcohol as an aid in the management of spastic cerebral palsy. Dev Med Child Neurol 1980; 22:497-501.
80. Brazeau GA, Fung HL: Mechanisms of creatine kinase release from isolated rat skeletal muscles damaged by propylene glycol and ethanol. J Pharm Sci 1990; 79(5):393-397.
81. Burgener FA, Steinmetz SD: Treatment of experimental adenocarcinomas by percutaneous intratumoral injection of absolute ethanol. Invest Radiol 1987; 22(6):472-478.
82. Papini E, Pacella CM, Verde G: Percutaneous ethanol injection (PEI): what is its role in the treatment of benign thyroid nodules? Thyroid 1995; 5(2):147-150.
83. Kitaoka M, Fukagawa M, Ogata E, Kurokawa K: Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients. Kidney Int 1994; 46(4):1110-1117.
84. de Lorimier AA: Sclerotherapy for venous malformations. J Pediatr Sur 1995; 30(2):188-193.
85. O'Hanlan JT, Galford HR, Bosley J: The use of 45% alcohol to control spasticity. Virginia Med Monthly 1969; 96:429-436.
86. Wong GY, Brown DL: Transient paraplegia following alcohol celiac plexus block. Reg Anesth 1995; 20(4):352-355.
87. Somma-Mauvais H, Poujet J, Guériot-Milandre C, Grob JJ, Bonerandi JJ, Gastaut JL: Trigeminal neurotrophic ulcer and vascular disorders of the brain stem. A clinico-electrophysiological study. Rev Neurol (Paris) 1992; 148(11):708-712.
88. Truscelli J. Personal communication.
89. Cockin J, Hamilton EA, Nicholds PJR, Price DA: Preliminary report on the treatment of spasticity with 45% ethyl alcohol injection into the muscles. Br J Clin Prac 1971; 25:73-75.
90. Pélissier J, Viel E, Enjalbert M, Kotzki N, Eledjam JJ: Chemical neurolysis using alcohol (alcoholization) in the treatment of spasticity in the hemiplegic. Can Anesthesiol 1993; 41(2):139-143.
91. Creswell LL, Rosenbloom M; Pirolo JS, Saffitz JE, Cox JL: Potential ablation of accessory atrioventricular pathways: injection of alcohol into the atrioventricular groove. Ann Thorac Surg 1994; 57(1):203-207.
92. Sun CF, Li ZJ, Wu LH, Xu LT, Wu N, Fan W, Jin L, Fang Q: Successful surgical treatment of three cases of type A Wolff Parkinson White syndrome using intramyocardial injection of absolute alcohol. Proc Chin Acad Med Sci Peking Union Med Coll 1987; 2(3):165-167.
93. Khao ShV, Dan ChV, Dzhi ChV: Treatment of Wolff Parkinson White syndrome by local myocardial injection of absolute alcohol. Grud-Serdechnososudistaia Khir 1990; 4:63-64.
94. DeLateur BJ: A new technique of intramuscular phenol neurolysis. Arch Phys Med Rehabil 1972; 53:179-185.
95. Awad EA: Intramuscular neurolysis for stroke. Minn Med 1972; 8:711-713.
96. Garland DE, Lucie RS, Waters RL: Current uses of open phenol block for adult acquired spasticity. Clin Orthop 1982; 165:217-222.
97. Moore TJ, Anderson RB. The use of open phenol blocks to the motor branches of the tibial nerve in adult acquired spasticity. Foot Ankle 1991; 11: 219-221.
98. Spira R: Management of spasticity in cerebral palsied children by peripheral nerve block with phenol. Dev Med Child Neurol 1971; 13:164-173.
99. Kenyon EM, Seeley ME, Janszen D, Medinsky MA: Dose-, route- and sex-dependent urinary excretion of phenol metabolites in B6C3F1 mice. J Toxicol Environ Health 1995; 44(2):219-233.
100. Chen H, Eastmond DA: Synergistic increase in chromosomal breakage within the euchromatin induced by an interaction of the benzene metabolites phenol and hydroquinone in mice. Carcinogenesis 1995; 16(8):1963-1969.
101. Burkel WE, McPhee M. Effect of phenol injection into peripheral nerve of rat: electron microscope studies. Arch Phys Med Rehabil 1970; 51:391-397.
102. Okazaki A: The effects of two and five percent aqueous phenol on the cat tibial nerve in situ. II. Effect on the circulation of the tibial nerve. Masui 1993; 42(6):819-825.
103. Mooney V, Frykman G, McLamb J: Current status of intraneural phenol injections. Clin Orthop 1969; 63:122-131.
104. Trigaux JP, Decoene B, Van Beers B: Focal necrosis of the ureter following CT-guided chemical sympathectomy. Cardiovasc Intervent Radiol 1992; 15(3):180-182.
105. de Micheli A, Medrano GA: Response of experimental ventricular tachycardia to class I antiarrhythmia agents. Arch Inst Cardiol Mex 1992; 62(1):11-24.
106. Halpern D: Histologic studies in animals after intramuscular neurolysis with phenol. Arch Phys Med Rehabil 1977; 58:438-443.
107. Holland AJC, Youssef M: A complication of subarachnoid phenol blockade. Anaesthesia 1978; 34:260-262.
108. Morgan RJ, Steller PH: Acute paraplegia following intrathecal phenol block in the presence of occult epidural malignancy. Anesthesia 1994; 49(2):142-144.
109. Katz JA, Sehlhorst S, Blisard KS: Histopathological changes in primate spinal cord after single and repeated epidural phenol administration. Reg Anest. 1995; 20(4):283-290.
110. Tekkok IH, Carter DH, Brinker R: Spinal subdural haematoma as a complication of immediate epidural blood patch. Can J Anaesth 1996; 43(3):306-309.
111. O'Rahilly R. Gardner-Gray-O'Rahilly: Anatomy: a Regional Study of Human Structure. 5th Edition. Philadelphia, WB Saunders, 1986.
112. Okazaki A: The effects of two and five percent aqueous phenol on the cat tibial nerve in situ. I. The local anesthetic-like effect of aqueous phenol. Masui 1993; 42(5):726-732.
113. Wood KE: The use of phenol as a neurolytic agent: a review. Pain 1978; 5:205-229.
114. Fusfeld RD: Electromyographic findings after phenol blocks. Arch Phys Med Rehabil 1968; 49: 217-220.
115. Glass A, Cain HD, Liebgold H, Mead S: Electromyographic and evoked potential responses after phenol blocks of peripheral nerves. Arch Phys Med Rehabil 1968; 49:455-459.
116. Bodine-Fowler SC, Allsing S, Botte MJ: Time course of muscle atrophy and recovery following a phenol-induced nerve block. Muscle Nerve 1996; 19(4):497-504.
117. Kizelshteyn G, Bairamian M, Inchiosa MA Jr, Chase JE: Enhancement of bupivacaine sensory blockade of rat sciatic nerve by combination with phenol. Anesth Analg 1992; 74(4):499-502.
118. Fisher E, et al.: Recovery of nerve conduction after nerve block by phenol. Am J Phys Med 1971; 50:230-234.
119. Burman MS: Therapeutic use of curare and erythroidine hypochloride for spastic and dystonic states. Arch Neurol Psychiat 1939; 41:307-327.
120. Petrillo CR, Chu DS, Davis SW: Phenol block of the tibial nerve in the hemiplegic patient. Orthopedics 1980; 3:871-874.
121. Helweg-Larsen J, Jacobsen E: Treatment of spasticity in cerebral palsy by means of phenol nerve block of peripheral nerves. Dan Med Bull 1969; 16:20-25.
122. Braun RM, et al.: Phenol nerve block in the treatment of acquired spastic hemiplegia in the upper limb. J Bone Joint Surg 1973; 55A:580-585.
123. Macek K: Medical News: Venous thrombosis results from some phenol injections. JAMA 1983; 249:1807.
124. Felsenthal G: Pharmacology of phenol in peripheral nerve blocks: a review. Arch Phys Med Rehabil. 1974; 55:13-16.
125. Itoh M.:The role of brain acetylcholine in phenol-induced tremor in mice. Arch Oral Biol 1995; 40(5):365-372.
126. Garland DE, Lilling M, Keenan MA: Percutaneous phenol blocks to motor points of spastic forearm muscles in head-injured adults. Arch Phys Med Rehabil 1984; 65:243-245.
127. Easton JKM, Ozel T, Halpern D: Intramuscular neurolysis for spasticity in children. Arch Phys Med Rehabil 1979; 60:155-158.
128. Sun X: Investigation on injectional gluteal muscle contracture childhood in MyanYang City. Chung Hua Liu Hsing Ping hsueh Tsa Chih 1990; 11(5):291-294.
129. Khalili AA: Physiatric Management of Spasticity by Phenol Nerve and Motor Point Block, in Ruskin AP (ed): Current Therapy in Physiatry. Philadelphia, WB Saunders, 1984.
130. Meelhuysen FE, Halpern D, Quast J: Treatment of flexor spasticity of hip by paravertebral lumbar spinal nerve block. Arch Phys Med Rehabil 1968; 49:36-41.
131. Katz J, Knott LW, Feldman DJ: Peripheral nerve injections with phenol in the management of spastic patients. Arch Phys Med Rehabil 1967; 48: 97-99.
132. Griffith ER, Melampy CN: General anesthesia used in phenol intramuscular neurolysis in young children with spasticity. Arch Phys Med Rehabil 1977; 58:154-157.
133. Walthard KM, Tchicaloff M: Motor points, in Licht S (ed): Electrodiagnosis and Electromyography, 3rd Ed. New Haven, Licht, 1971.
134. Lapicque L: Has the muscular substance a longer chronaxie than the nervous substance? J Physiol (Lond) 1931; 73:189-214.
135. Zack SI: The Motor Endplate. Philadelphia, WB Saunders, 1971.
136. Aquilonius SM, Askmark H, Gillberg PG, Nandedkar S, Olsson Y, Stalberg E: Topographical localization of motor endplates in cryosections of whole human muscles. Muscle Nerve 1984; 7:287-293.
137. Buchtal F, Rosenthal P: Spontaneous electrical activity of human muscle. Electroencephalogr Clin Neurophysiol 1966; 20:321-336.
138. Wiederholt WC: "End-plate noise" in electromyography. Neurology 1970; 20:214-224.
139. Jones RV Jr, Lambert EH, Sayre GP: Source of type of insertion activity in electromyography with evaluation of histologic method of localization. Arch Phys Med 1955; 36:301-310.
140. Labib KB, Gans BM: Chemical neurolysis: technique and anatomical consideration (videotape). Boston, Dept of Rehabilitation Medicine, New England Medical Center, 1984.
141. Felsenthal G: Nerve blocks in the lower extremities: anatomic considerations. Arch Phys Med Rehabil 1974; 55:504-507.
142. Massey JM: Treatment of spasmodic torticollis with intramuscular phenol injection (letter). J Neurol Neurosurg Psychiatry 1995; 58(2):258-259.
143. Santos G, Novell JR, Khoury G, Winslet MC, Lewis AA: Long-term results of large-dose, single session phenol injection sclerotherapy for hemorhoids. Dis Colon Rectum 1993; 36(10): 958-961.
144. Supe AN, Mathur SK, Borwankar SS: Esophageal endoscopic sclerotherapy in children using 3% aqueous phenol. Indian J Gastroenterol 1994; 13(1):1-4.
145. Chiba K: An experimental study on the pathological changes of the intervertebral disc and its surrounding tissues after intradiscal injection of various chemical substances (the first report). Nippon Seikeigeka Gakkai Zasshi 1993; 67(11): 1055-1069.
146. Birch M, Strong N, Brittain P, Sandford-Smith J: Retrobulbar phenol injection in blind, painful eyes. Ann Ophthalmo 1993; 25(7):267-270.
147. Bennani S: Evaluation of sub-trigonal injections in the treatment of the hyperactive bladder. Ann Urol Paris 1994; 28(1):13-19.
148. Greenstein D, Brown TF, Kester RC: Assessment of chemical lumbar sympathectomy in critical limb ischemia using thermal imaging. Int J Clin Monit Comput 1994; 11(1):31-34.
149. Neuberger TJ, Wittgen CM, Schneider TA 2nd, Andrus CH, Panneton WM, Kaminski DL: Evaluation of alternative proximal gastric vagolomy techniques alter a 9-month interval in a rat model. Gastrointest Endosc 1994; 40(3):316-320.
150. Yamauchi Y, Kojoh H, Nagaro T, Miyasaki H, Kimura S, Arai T: Treatment of hyperhydrosis with caudal epidural alcohol block in a patient with cervical cord injury. Masui 1993; 42(4): 606-610.